[What is proven in the treatment of COPD?].

Der Internist
H Worth

Abstract

The treatment of chronic obstructive pulmonary disease (COPD) with or without emphysema includes prevention, management of exacerbation and of stable disease. Smoking cessation is the most important intervention to reduce the risk of developing COPD and stop its progression. Bronchodilator medications and inhaled glucocorticosteroids are given to reduce symptoms and exacerbations in long-term medical therapy. Pulmonary rehabilitation including exercise training and patient education improves symptoms and morbidity. The management of exacerbations includes intensified treatments with bronchodilators, systemic corticosteroids for 10-14 days, as well as the use of O(2) for patients with hypoxia and non invasive or invasive ventilation in the case of acidosis and hypercapnia.

References

Sep 22, 1994·The New England Journal of Medicine·K L NicholT Von Sternberg
Mar 8, 2003·Archives of Internal Medicine·Jean BourbeauUNKNOWN Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec
May 22, 2003·The New England Journal of Medicine·Alfred FishmanUNKNOWN National Emphysema Treatment Trial Research Group
Mar 5, 2004·Patient Education and Counseling·H Worth, Y Dhein
Jun 29, 2004·The European Respiratory Journal·D E O'DonnellH Magnussen
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Feb 5, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·UNKNOWN Asia Pacific COPD Roundtable Group
Jun 9, 2006·American Journal of Respiratory and Critical Care Medicine·Linda NiciUNKNOWN ATS/ERS Pulmonary Rehabilitation Writing Committee
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Apr 17, 2007·Pneumologie·C VogelmeierUNKNOWN Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Dec 18, 2007·Pharmazie in unserer Zeit·Christiane Meyer Ständigen Impfkommission am Robert Koch-Institut
Feb 8, 2008·The European Respiratory Journal·D P TashkinS Kesten
May 8, 2008·Pneumologie·S AndreasUNKNOWN Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin
Oct 7, 2008·The New England Journal of Medicine·Donald P TashkinUNKNOWN UPLIFT Study Investigators
Nov 18, 2008·Pneumologie·H MagnussenUNKNOWN Deutsche Gesellschaft Für Pneumologie und Beatmungsmedizin e.V
May 7, 2009·Thorax·J BottUNKNOWN British Thoracic Society Physiotherapy Guideline Development Group
Jun 23, 2009·The European Respiratory Journal·M P MurrayA T Hill

❮ Previous
Next ❯

Citations

Apr 19, 2015·International Journal of Health Geographics·Dorothea LemkeHans-Werner Hense

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.